drugset / Trial / NCT05362110
A Study to Evaluate Efficacy and Safety of HCP1803 in Patients With Essential Hypertension
RandomizedParallel-groupDouble-blindTreatment
Summary
A multicenter, randomized, double-blind, phase 3 study to evaluate efficacy and safety of HCP1803 in patients with essential hypertension
Timeline
- Start
- 2022-05-16
- Primary completion
- 2023-06-05
- Completion
- 2023-06-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HCP1803-3 | Unknown | — | Oral |
| Comparator | RLD2002 | Unknown | — | Oral |